Key Points Big pharma companies are jostling for position in the weight loss market. A larger pharma company may decide it's worth taking Viking's promising drug candidate through phase 3. 10 stocks we like better than Viking Therapeutics › Shares in Viking Therapeutics (NASDAQ: VKTX) were up more than 16% in the week to Thursday at 1 pm. The move comes after the announcement of another acquisition of a small-cap biopharmaceutical company by a pharmaceutical giant. This time, it's Novo Nordisk payi ...